The new formulation of OncoZenge’s drug candidate BupiZenge™ is clean
OncoZenge can today confirm that comprehensive analyses show that the adjusted formulation of BupiZenge™ is clean. Stability studies will now continue as planned. The company asserts that a clean and stable product formulation has great commercial value for potential licensees and strategic partners, as a proven, working product is the basis for continued clinical study and an eventual market approval.As announced in the financial report for the third quarter, the company has for some time analyzed the cause of the previously announced impurity in the lozenge formulation of BupiZengeTM. The